What Managed Care Needs to Know About Chronic Cough: Novel Therapies for Improved Outcomes

A continuing medical education activity provided by NAMCP and AAMCN

Novel Treatment Advances and Approaches in the Management of Chronic Cough With Unexplained Cause: Emerging Therapies for Improved Clinical and Economic Outcomes is a two-part webinar series
focusing on the improved clinical and economic outcomes with chronic cough

This is Part 2 of the series on chronic cough

This activity is an archive from the webinar held August 25, 2020

This activity is valid from September 1, 2020 to September 1, 2022

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.


Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from
Merck Sharp & Dohme Corp.

Chronic cough, which is observed in approximately 12% of the US population, is defined as a cough that lasts for more than 8 weeks. Patients with chronic cough are often distressed by the condition, which can lead to depression, anxiety, a decline in quality of life, and changes to their social activities. The diagnosis and management of chronic cough can be challenging, with only approximately 50% of patients receiving a diagnosis. Recent advances have been made in the understanding and management of refractory chronic cough, with several novel therapies being evaluated in ongoing clinical studies. This educational activity will review the burden of chronic cough, discuss the current recommendations for the management of patients with chronic cough, and evaluate the latest clinical data regarding emerging pharmacotherapies for the treatment of patients with refractory chronic cough.

Upon completion of this activity, participants will be able to:

  • Review the economic burden of chronic cough, particularly in patients who do not find relief from recommended management strategies

  • Analyze the mechanisms of action as well as the latest clinical data regarding emerging pharmacotherapies to treat patients with refractory chronic cough

  • Examine managed care considerations of emerging P2X3 receptor antagonists in the management of refractory or unexplained chronic cough

  • Discuss the role of managed care professionals within the collaborative care team for effective therapy management for patients with chronic cough

Faculty: Gary Owens, MD
Gary Owens Associates


Dr. Owens has no relevant financial relationships to disclose.
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Jeremy Williams has no real or perceived financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no real or perceived financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association of Managed Care Physicians (NAMCP) and American Association of Managed Care Nurses (AAMCN). The National Association of Managed Care Physicians is accredited by the ACCME to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in nursing continuing professional development.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This activity is supported by an educational grant from
Merck Sharp & Dohme Corp.

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue